Header

UZH-Logo

Maintenance Infos

Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma


Statistics

Citations

Dimensions.ai Metrics
108 citations in Web of Science®
111 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

252 downloads since deposited on 30 Aug 2017
101 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Oncology
Life Sciences > Cancer Research
Language:English
Date:13 June 2017
Deposited On:30 Aug 2017 13:09
Last Modified:26 Jan 2022 13:25
Publisher:American Association for Cancer Research
ISSN:1078-0432
OA Status:Hybrid
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1158/1078-0432.CCR-16-2923
PubMed ID:28611198
  • Content: Accepted Version